Clinical Trial: Molecular and IHC Profiling of PTH Tumors to Evaluate Targeted Agents

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Molecular and Immunohistochemical Profiling of Tumor From Patients With Parathyroid Tumors for Evaluation of Targeted Agents

Brief Summary: This is a pilot biomarker study designed to compare frequencies of mutations between groups of malignant, benign and normal tissue or blood of patients with parathyroid disease and identify the potential genes showing molecular aberrations as other types of cancer.